Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07603713 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of LP-005 Injection in Patients With Moderate-to-Severe Periodontitis

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This is a multicenter, randomized, double-blind, placebo-controlled Phase II clinical study designed to evaluate the clinical efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of multiple local injections of different doses of LP-005 injection in patients with moderate-to-severe periodontitis, and to investigate changes in biomarker levels.
Trial Details
NCT Number NCT07603713
Lead Sponsor Longbio Pharma (Suzhou) Co., Ltd.
Conditions
(from sponsor)		 Periodontitis
Related terms Periodontitis
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov